Intraocular invasion by conjunctival squamous cell carcinoma: clinical presentation, histopathological findings and outcome

Ysé Borella, L. Lumbroso-Le Rouic, Christine Lévy, Sophie Gardrat, Jerzy Klijanienko, Denis Malaise, Rémi Dendale, Nathalie Cassoux, Alexandre Matet
{"title":"Intraocular invasion by conjunctival squamous cell carcinoma: clinical presentation, histopathological findings and outcome","authors":"Ysé Borella, L. Lumbroso-Le Rouic, Christine Lévy, Sophie Gardrat, Jerzy Klijanienko, Denis Malaise, Rémi Dendale, Nathalie Cassoux, Alexandre Matet","doi":"10.1159/000531983","DOIUrl":null,"url":null,"abstract":"Purpose: Intraocular localization of conjunctival squamous cell carcinoma (SCC) is due to scleral or corneal invasion. Herein we describe the clinical and histopathological findings in four cases of SCC complicated by intraocular invasion, and we review cases reported in the literature and their management. Methods: We retrospectively collected and analyzed clinical characteristics, histopathology, management, and follow-up data from four patients with conjunctival squamous cell carcinoma complicated by intraocular invasion. We reviewed the literature and summarized cases of intraocular invasion by conjunctival SCC reported over the last 30 years. Results: Two patients presented with intraocular invasion by conjunctival SCC at diagnosis. The two others developed intraocular invasion as recurrence of conjunctival SCC, previously treated with excisional biopsy and adjuvant radiotherapy. All four cases had a previous history of conjunctival surgery, but no history of intraocular surgery. Three patients were managed with modified enucleation, including one that required adjuvant orbital radiotherapy. One patient required orbital exenteration. Histopathology analysis showed a well-differentiated conjunctival SCC in all cases. None developed distant localization after at least 2.5-years follow-up. Conclusions: Intraocular invasion is a rare complication of conjunctival SCC. Appropriate treatment in a tertiary center and long-term follow-up are highly recommended.","PeriodicalId":506981,"journal":{"name":"Ocular Oncology and Pathology","volume":"48 7","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-11-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Ocular Oncology and Pathology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1159/000531983","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose: Intraocular localization of conjunctival squamous cell carcinoma (SCC) is due to scleral or corneal invasion. Herein we describe the clinical and histopathological findings in four cases of SCC complicated by intraocular invasion, and we review cases reported in the literature and their management. Methods: We retrospectively collected and analyzed clinical characteristics, histopathology, management, and follow-up data from four patients with conjunctival squamous cell carcinoma complicated by intraocular invasion. We reviewed the literature and summarized cases of intraocular invasion by conjunctival SCC reported over the last 30 years. Results: Two patients presented with intraocular invasion by conjunctival SCC at diagnosis. The two others developed intraocular invasion as recurrence of conjunctival SCC, previously treated with excisional biopsy and adjuvant radiotherapy. All four cases had a previous history of conjunctival surgery, but no history of intraocular surgery. Three patients were managed with modified enucleation, including one that required adjuvant orbital radiotherapy. One patient required orbital exenteration. Histopathology analysis showed a well-differentiated conjunctival SCC in all cases. None developed distant localization after at least 2.5-years follow-up. Conclusions: Intraocular invasion is a rare complication of conjunctival SCC. Appropriate treatment in a tertiary center and long-term follow-up are highly recommended.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
结膜鳞状细胞癌的眼内侵犯:临床表现、组织病理学结果和预后
目的:结膜鳞状细胞癌(SCC)的眼内定位是由于巩膜或角膜受侵所致。在此,我们描述了四例并发眼内侵犯的 SCC 的临床和组织病理学结果,并回顾了文献中报道的病例及其处理方法。研究方法我们回顾性地收集并分析了四例结膜鳞状细胞癌并发眼内侵犯患者的临床特征、组织病理学、处理和随访数据。我们查阅了相关文献,总结了过去 30 年中报道的结膜鳞状细胞癌眼球内侵犯病例。结果:两名患者在确诊时已出现结膜SCC眼内侵犯。另外两名患者是结膜SCC复发引起的眼内侵犯,之前曾接受过切除活检和辅助放疗治疗。所有四例患者均有结膜手术史,但没有眼内手术史。三名患者接受了改良的眼球摘除术,其中一名患者需要接受眼眶辅助放疗。一名患者需要进行眼眶外扩张术。组织病理学分析显示,所有病例均为分化良好的结膜 SCC。随访至少2.5年后,无一例出现远处定位。结论:眼内侵犯是结膜 SCC 的罕见并发症。强烈建议在三级医疗中心进行适当治疗并进行长期随访。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Adjuvant brachytherapy with ruthenium-106 to reduce the risk of recurrence of conjunctival melanoma after excision Clinicopathological Correlates of Ocular Surface Squamous Neoplasia Neoadjuvant Chemotherapy in Non-Metastatic Eyelid Sebaceous Gland Carcinoma - Report in 10 Cases MEK Inhibitor-Associated Ocular Hypertension Intraocular invasion by conjunctival squamous cell carcinoma: clinical presentation, histopathological findings and outcome
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1